SOL ARENA USHERS IN A NEW ERA OF CASUAL GAMING AND CRYPTO WAGERING ON SOLANA, WITH $CHILL TOKEN LAUNCHING SOON
SOL Arena, the Web3 multiplayer battle game developed by Chillchat, will launch its $CHILL token at end-March 2025, following its sold-out Challengers NFT mint on Magic Eden on February 6, 2025. Delivering a fresh take on snake-like gameplay on the...
Smartpay Announces Japan's First "Embedded Insurance Service" in BNPL in Partnership with Chubb
~ Launching New Insurance Experience Integrating Payments and Insurance in Summer 2025 TOKYO, March 6, 2025 /PRNewswire/ -- Smartpay Corporation (Headquarters: Minato-ku, Tokyo; Sam Pemberton-Ahmed, CEO and Founder of Smartpay; hereinafter "the...
Transforming Sales: 6D Technologies Empowers Filipino Mobile Services Provider Smart
BARCELONA, Spain, March 6, 2025 /PRNewswire/ -- 6D Technologies announces the successful deployment of Ventas, its advanced Sales & Distribution solution, for Smart Communications, Inc. (Smart), the wireless unit of PLDT Inc. (PLDT), the...
Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors
KUALA LUMPUR, Malaysia, March 6, 2025 /PRNewswire/ -- Wahed, a global Shariah-compliant fintech has appointed Shahril Hamdan to its Board of Directors. Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors. Shahril Hamdan...
Movement Labs Announces "GMove: Move Asia's Future" APAC Tour Following Mainnet Launch
SAN FRANCISCO, March 6, 2025 /PRNewswire/ -- Movement Labs, a Web3 company and core contributor of the Movement Network, today announced the launch of its Asia Pacific tour: "GMove: Move Asia's Future." This comprehensive tour will connect...
HKA WELCOMES ADAM SMITH AS A PRINCIPAL IN THE ADVISORY TEAM IN AUSTRALIA
SYDNEY, March 6, 2025 /PRNewswire/ -- HKA, a leading infrastructure project, strategy, commercial advisory and dispute resolution company, is delighted to announce the appointment of Adam Smith to our Advisory team in Australia. Adam joins our...
Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma
HONG KONG, March 6, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical trial (COMPASSION-22/AK104-306) evaluating cadonilimab,...
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being investigated globally in a multi-center Phase Ib...